In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection

被引:72
作者
Blaak, H
Brouwer, M
Ran, LJ
de Wolf, F
Schuitemaker, H
机构
[1] Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Dept Clin Viroimmunol, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Expt & Clin Immunol Lab, Amsterdam, Netherlands
关键词
D O I
10.1086/514219
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In 7 long-term survivors (LTS) and 8 progressors, all carrying solely non-syncytium-inducing variants, a possible correlation between in vitro virus replicative capacity, virus load, and clinical course of human immunodeficiency virus type 1 (HIV-1) infection was analyzed, Late in infection, 3 LTS and 7 progressors had a high virus load, which coincided with the presence of rapid-replicating viruses, In contrast to progressors, LTS maintained relatively high and stable CD4 T cell counts, Four LTS persistently had relatively slow-replicating viruses and a low virus load, even after 6.6-9 years of seropositive follow-up. All virus isolates from 1 of these LTS had a 4-aa deletion in nef, These results suggest a correlation between the in vitro replicative capacity of non-syncytium-inducing HIV-1 variants and virus load, The presence of HIV-I variants with relatively low replicative capacity throughout infection may have contributed to the beneficial clinical course in half of the LTS in this study.
引用
收藏
页码:600 / 610
页数:11
相关论文
共 60 条
  • [1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
    Alkhatib, G
    Combadiere, C
    Broder, CC
    Feng, Y
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
  • [2] ASJO B, 1986, LANCET, V2, P660
  • [3] Temporal relationship between human immunodeficiency virus type 1 RNA levels in serum and cellular infectious load in peripheral blood
    Blaak, H
    deWolf, F
    vantWout, AB
    Pakker, NG
    Bakker, M
    Goudsmit, J
    Schuitemaker, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) : 1383 - 1387
  • [4] RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS
    BOOM, R
    SOL, CJA
    SALIMANS, MMM
    JANSEN, CL
    WERTHEIMVANDILLEN, PME
    VANDERNOORDAA, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) : 495 - 503
  • [5] A CROSS-SECTIONAL COMPARISON OF PERSONS WITH SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS
    BOZZETTE, SA
    MCCUTCHAN, JA
    SPECTOR, SA
    WRIGHT, B
    RICHMAN, DD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) : 1374 - 1379
  • [6] VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    CAO, YZ
    QIN, LM
    ZHANG, LQ
    SAFRIT, J
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) : 201 - 208
  • [7] BIOLOGIC FEATURES OF HIV-1 THAT CORRELATE WITH VIRULENCE IN THE HOST
    CHENGMAYER, C
    SETO, D
    TATENO, M
    LEVY, JA
    [J]. SCIENCE, 1988, 240 (4848) : 80 - 82
  • [8] The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
    Choe, H
    Farzan, M
    Sun, Y
    Sullivan, N
    Rollins, B
    Ponath, PD
    Wu, LJ
    Mackay, CR
    LaRosa, G
    Newman, W
    Gerard, N
    Gerard, C
    Sodroski, J
    [J]. CELL, 1996, 85 (07) : 1135 - 1148
  • [9] OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE
    CHOWERS, MY
    SPINA, CA
    KWOH, TJ
    FITCH, NJS
    RICHMAN, DD
    GUATELLI, JC
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (05) : 2906 - 2914
  • [10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION
    CONNOR, RI
    HO, DD
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4400 - 4408